Your browser doesn't support javascript.
loading
Phantom vision after eye removal: prevalence, features and related risk factors.
Martel, Arnaud; Baillif, Stephanie; Thomas, Pierre; Almairac, Fabien; Galatoire, Olivier; Hamedani, Mehrad; Fontaine, Denys; Lanteri-Minet, Michel.
Afiliação
  • Martel A; Ophthalmology, University Hospital Centre Nice, Nice, Provence-Alpes-Côte d'Azur, France arnaudmartel@hotmail.fr.
  • Baillif S; Ophthalmology, University Hospital Centre Nice, Nice, Provence-Alpes-Côte d'Azur, France.
  • Thomas P; Neurology, University Hospital Centre Nice, Nice, Provence-Alpes-Côte d'Azur, France.
  • Almairac F; Neurosurgery, University Hospital Centre Nice, Nice, Provence-Alpes-Côte d'Azur, France.
  • Galatoire O; Oculoplastics, Fondation Rothschild, Paris, Île-de-France, France.
  • Hamedani M; Hôpital Ophtalmique Jules Gonin, Lausanne, VD, Switzerland.
  • Fontaine D; Neurosurgery, University Hospital Centre Nice, Nice, Provence-Alpes-Côte d'Azur, France.
  • Lanteri-Minet M; Pain Evaluation and Management Department, University Hospital of Nice, Fédération Hospitalo-Universitaire InovPain, Cote d'Azur University, University Hospital Centre Nice, Nice, Provence-Alpes-Côte d'Azur, France.
Br J Ophthalmol ; 106(11): 1603-1609, 2022 11.
Article em En | MEDLINE | ID: mdl-33980507
AIM: Phantom eye syndrome is a poorly understood and underestimated complication of eye removal (ER). Seeing with the amputated eye, referred to as phantom vision (PV), is undoubtedly the most intriguing and confusing complication experienced by anophthalmic patients. The aim of the study was to assess PV prevalence, clinical features and risk factors after ER. METHODS: A multicentric questionnaire-based study was conducted between April 2016 and July 2017. Patients >18 years who underwent ER >3 months ago had a socket examination before inclusion. Data recorded included patients' demographics, and preoperative, surgical and postoperative features. RESULTS: One hundred patients (53 men) with a mean age of 65.1 years (29-92; SD=13.0) were included. ER indications were: uveal melanoma (n=24, 24%), trauma (n=20, 20%), retinal detachment (n=20, 20%), glaucoma (n=14, 14%) and endophthalmitis (n=12, 12%). Thirty (30%) patients experienced PV. Elementary and complex visual hallucinations were experienced by 80% and 20% of patients, respectively. PV usually appeared within the first postoperative month and tended to decrease over time. Risk factors for PV were the preoperative use of proton beam therapy (p=0.006), uveal melanoma (p=0.014), enucleation (p=0.015), anxiety with a Hospital and Anxiety Depression (HAD) score ≥8 (p=0.042), depression with a HAD score ≥8 (p=0.030), phantom eye pain (p=0.044) and phantom eye sensations (p=0.002). CONCLUSION: PV was reported by one-third of our patients. Despite being widely misunderstood, ophthalmologists and neurologists should be aware of this complication to adequately reassure patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uveais Tipo de estudo: Clinical_trials / Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uveais Tipo de estudo: Clinical_trials / Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article